Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $45.0B | $42.8B | $40.7B | $37.2B | $40.2B | $41.1B | $51.5B | $52.3B | $47.7B | $42.0B | $40.0B | $39.2B | $40.5B | $41.3B | $42.4B | $41.5B | $33.2B | $50.5B | $66.0B | $28.8B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Pfizer Inc.'s last 12-month Gross Profit is $35.5B, based on the financial report for Sep 29, 2024 (Q3 2024).
Over the last year, Pfizer Inc.'s Gross Profit growth was (5.6%). The average annual Gross Profit growth rates for Pfizer Inc. have been (2.4%) over the past three years, (3.5%) over the past five years.
Over the last year, Pfizer Inc.'s Gross Profit growth was (5.6%), which is lower than industry growth of 0.3%. It indicates that Pfizer Inc.'s Gross Profit growth is Bad.